Evidence map›Paper›PMID 29784471›Full record

ArticleVaccine2018

Rotavirus gastroenteritis surveillance in Azerbaijan, 2011-2016.

Nazifa Mursalova, Nazim Shugayev, Javahir Suleymanova, Danni S Daniels, Annemarie Wasley, Adam L Cohen, Negar Aliabadi

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Nazifa MursalovaMinistry of Health of Azerbaijan, National Program, Baku, Azerbaijan.
Nazim ShugayevImmunological Laboratory of the Republican Anti-plague Station, National Laboratory for the Diagnosis of Rotavirus Enteritis, Baku, Azerbaijan.
Javahir SuleymanovaWorld Health Organization, Country Office, Baku, Azerbaijan.
Danni S DanielsVaccine-preventable Diseases and Immunization, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
Annemarie WasleyVaccine-preventable Diseases and Immunization, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
Adam L CohenExpanded Programme on Immunization, World Health Organization, Geneva, Switzerland.
Negar AliabadiDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: ydh6@cdc.gov.
World Health Organization Regional Office for Europe · DKMinistry of Healthcare · AZNational Center for Immunization and Respiratory Diseases · USNational Nuclear Research Center · AZWorld Health Organization · CH

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

introductionRotavirus is a leading cause of acute gastroenteritis and mortality among children worldwide but data describing rotavirus disease in Azerbaijan are lacking. This analysis describes the rotavirus disease burden in Baku, the largest city in Azerbaijan.

methodsWe conducted active, prospective, sentinel hospital surveillance with laboratory confirmation for rotavirus among children under 5 years of age hospitalized at a large pediatric hospital in Baku during 2011-2016. Children with bloody diarrhea, or prior use of antibiotics or intravenous fluids were excluded. The guardians of enrolled children completed a questionnaire documenting clinical and demographic information. A stool specimen was collected from each enrolled child. We report the number and proportion of rotavirus positive hospitalizations during the surveillance period and a clinical description of rotavirus-positive and rotavirus-negative children.

resultsFrom July 2011 through June 2016, 3139 children <5 years of age were enrolled into the surveillance system. Of these, 523 (17%) were positive for rotavirus, varying from 13% to 21% by surveillance year, with a median of 16% over the surveillance period. Increase in rotavirus detections occurred during December-May. Most rotavirus infections (303/523; 58%) occurred in children aged 6-23 months.

conclusionRotavirus is responsible for approximately 16% of annual hospital admissions for acute gastroenteritis in children <5 years of age in Baku. This is lower than regional estimates. Exclusion of children with a history of antibiotic use or intravenous fluids may be accounting for this lower prevalence, and expansion of surveillance to include these groups could provide a more comprehensive picture of acute rotavirus gastroenteritis in Baku.

Indexed as

Sentinel SurveillanceAzerbaijanChild, PreschoolCost of IllnessDiarrheaFecesFemaleGastroenteritisHospitalizationHumansImmunization ProgramsInfantInfant, NewbornLegal GuardiansMalePrevalenceAcute gastroenteritisDiarrhea surveillancePediatricRotavirus

Identifiers

PMID29784471
PMCPMC9169510
OpenAlexW2803341149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.